12 results
DEF 14A
CMRA
Comera Life Sciences Holdings, Inc.
11 Aug 23
Definitive proxy
4:15pm
board of directors with respect to accounting, financial, and other reporting and internal control practices and to oversee our independent registered … Listing Standards.
The primary purpose of our compensation committee is to discharge the responsibilities of our board of directors to oversee its
PRE 14A
CMRA
Comera Life Sciences Holdings, Inc.
1 Aug 23
Preliminary proxy
5:08pm
and to oversee our independent registered accounting firm. Our audit committee held 2 meetings during 2022.
Specific responsibilities of our audit committee … of directors to oversee its compensation policies, plans and programs and to review and determine the compensation to be paid to its executive
424B3
CMRA
Comera Life Sciences Holdings, Inc.
31 Mar 23
Prospectus supplement
4:34pm
with respect to accounting, financial, and other reporting and internal control practices and to oversee our independent registered accounting firm … the responsibilities of our board of directors to oversee its compensation policies, plans and programs and to review and determine the compensation to be paid to its
424B3
CMRA
Comera Life Sciences Holdings, Inc.
31 Mar 23
Prospectus supplement
4:34pm
the responsibilities of our board of directors with respect to accounting, financial, and other reporting and internal control practices and to oversee our independent … is to discharge the responsibilities of our board of directors to oversee its compensation policies, plans and programs and to review and determine
424B3
CMRA
Comera Life Sciences Holdings, Inc.
31 Mar 23
Prospectus supplement
4:32pm
to accounting, financial, and other reporting and internal control practices and to oversee our independent registered accounting firm.
Specific … of our board of directors to oversee its compensation policies, plans and programs and to review and determine the compensation to be paid to its
424B3
q9a5nvh fx4h7ais7w5m
15 Sep 22
Prospectus supplement
4:09pm
424B3
ldhri6zpjb7h3
28 Jun 22
Prospectus supplement
10:45am
8-K
8q7wba475sse
25 May 22
Index to Financial Statements
5:23pm
S-1
bvp1 1i2a4
4 May 22
IPO registration
9:23pm
- Prev
- 1
- Next